Evidence map›Paper›PMID 39185478›Full record

ArticleNature cardiovascular research2023

Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine.

Michael Lenaeus, Tamer M Gamal El-Din, Lige Tonggu, Ning Zheng, William A Catterall

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Calcium-activated chloride channel TMEM16A opens via pi-helical transition in transmembrane segment 4.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael LenaeusDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-1284-8052
Tamer M Gamal El-DinDepartment of Pharmacology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-7406-7393
Lige TongguDepartment of Pharmacology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-0033-556X
Ning ZhengDepartment of Pharmacology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-1039-1581
William A CatterallDepartment of Pharmacology, University of Washington, Seattle, WA, USA.ORCID 0000-0001-5509-3580

Funding

Structural Basis for Antiarrhythmic Drug ActionR01HL112808 · NHLBI · UNIVERSITY OF WASHINGTON · PI ZHENG, NING · 2012 to 2025
$7.8M
The Structural Basis of Antiarrhythmic Drug Binding in Voltage-gated Ion ChannelsK08HL145630 · NHLBI · UNIVERSITY OF WASHINGTON · PI LENAEUS, MICHAEL J · 2019 to 2023
$816k
Howard Hughes Medical InstituteNHLBI NIH HHS K08 HL145630NHLBI NIH HHS R01 HL112808
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Arrhythmia AgentsRanolazineAnimalsHumansNAV1.5 Voltage-Gated Sodium ChannelSodium Channel BlockersStructure-Activity RelationshipAnti-Arrhythmia AgentsNAV1.5 Voltage-Gated Sodium ChannelRanolazineSCN5A protein, humanSodium Channel Blockers

Identifiers

PMID39185478
PMCPMC11343317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.